You just read:

Ipsen Announces Data Presentations of Somatuline® Depot (lanreotide) Injection in Gastroenteropancreatic Neuroendocrine Tumors at American Society of Clinical Oncology Annual Meeting

News provided by

Ipsen Biopharmaceuticals, Inc.

Jun 02, 2016, 18:40 ET